Correlation Between Savara and Entrada Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Savara and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Entrada Therapeutics, you can compare the effects of market volatilities on Savara and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Entrada Therapeutics.

Diversification Opportunities for Savara and Entrada Therapeutics

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Savara and Entrada is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Savara i.e., Savara and Entrada Therapeutics go up and down completely randomly.

Pair Corralation between Savara and Entrada Therapeutics

Given the investment horizon of 90 days Savara Inc is expected to under-perform the Entrada Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Savara Inc is 1.02 times less risky than Entrada Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Entrada Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,336  in Entrada Therapeutics on September 2, 2024 and sell it today you would earn a total of  653.00  from holding Entrada Therapeutics or generate 48.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Savara Inc  vs.  Entrada Therapeutics

 Performance 
       Timeline  
Savara Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Entrada Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Savara and Entrada Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Savara and Entrada Therapeutics

The main advantage of trading using opposite Savara and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.
The idea behind Savara Inc and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges